central nervous system disorder Omics AI Software Firm Standigm Eyes 2024 IPO, Partnerships With Major Cloud Providers Premium A month into a collaboration with Nashville Biosciences, the Korean company is looking for additional partnerships with research institutions and Big Pharma to accelerate target discovery. Migraine GWAS Points to Subtype-Specific Loci, Potential Mechanisms Researchers linked migraine risk to 123 loci, including risk variants not found in the past and loci implicated in migraine subtypes. Expression-Based Survival Signature Proposed for Glioblastoma Using RNA sequence data from the Cancer Genome Atlas and the Chinese Glioma Genome Atlas, researchers identified six genes with expression ties to overall survival. MicroRNAs Provide Prognostic Clues in Primary Central Nervous System Lymphoma An array-based analysis involving more than two dozen patients led to a miRNA signature associated with overall survival in primary central nervous system lymphoma. Aggressive Meningioma Linked to Transcription Factor Activity The transcription factor FOXM1 marked meningioma cases with poorer outcomes and enhanced cell proliferation, based on integrated exome, expression, and epigenetic profiles. Mar 14, 2018 DNA Methylation Data Helps Refine Classification of Central Nervous System Tumors Aug 3, 2015 Generic Drug Manufacturer Teva Takes Majority Stake in Genomic Analysis Shop Immuneering Oct 10, 2013 Mt. Sinai, Berg Ink Omics Deal Directed at Cancer, CNS, Endocrine Disorders Dec 5, 2012 Roche, IMI Lead Stem Cell Research Effort Feb 24, 2012 NextGen Creates Diagnostics Subsidiary for CNS Test Development May 27, 2011 RBM Achieves Milestone in Companion Diagnostic Project with Roche Premium May 25, 2011 Evotec, PsychoGenics Partner on CNS Drug Discovery Services May 9, 2011 BD Diagnostics, Diagenode to Co-develop Assays on BD Max System Dec 24, 2010 Sanger, Edinburgh Scientists Complete First Proteomic Analysis of Human Postsynaptic Density Premium Nov 12, 2010 Takeda, Sage Bionetworks Partner to Find Drug Targets for CNS Breaking News Plasmid Transfer Let Cholera Pathogen in Yemen Become Multidrug Resistant, Study Suggests Harbinger Health Raises $140 Million in Series B Financing BioMérieux's BioFire Defense Secures $18.8M US DoD Contract for Infectious Disease Testing Biora Therapeutics Settles Claims of Misleading Genetic Testing Advertisements Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.